A simple index to assess disease activity in rheumatoid arthritis.
Changes in clinical and laboratory measures of disease activity were studied prospectively in 12 European centers. Altogether 282 rheumatoid patients were evaluated during 6 months of therapy with slow-acting drugs. Patients' global assessment was taken to indicate overall response. The number of swollen joints and number of tender joints correlated highly with this. The erythrocyte sedimentation rate (ESR) correlated less well but was more uniform across centers. Grip strength, C-reactive protein and hemoglobin performed poorly between centers. There were cultural and linguistic difficulties using the Health Assessment Questionnaire in a European setting. Physician's global assessments were similar to the patient's global assessments and provided redundant information. The best measures are: the number of swollen joints, the number of tender joints, the ESR, and the patient's global assessment. It may also help to measure articular pain.
Scott
D L
DL
Department of Rheumatology, St. Bartholomew's Hospital Medical College, London, UK.
D001172:Arthritis, Rheumatoid / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D002097:C-Reactive Protein / Q000032:analysis; D005060:Europe / Q000453:epidemiology; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007596:Joints / Q000473:pathology / Q000503:physiopathology; D015337:Multicenter Studies as Topic; D009132:Muscles / Q000473:pathology / Q000503:physiopathology; D017063:Outcome Assessment, Health Care; D010146:Pain; D011446:Prospective Studies; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D006454:Hemoglobins; D002097:C-Reactive Protein